Open AccessThe Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient
Author(s) -
Hiroji Iwata,
Shigehira Saji,
Masahiko Ikeda,
Masashi Inokuchi,
Takayoshi Uematsu,
Tatsuya Toyama,
Rie Horii,
Chikako Yamauchi
Publication year - 2019
Publication title -
breast cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.131
H-Index - 51
eISSN - 1880-4233
pISSN - 1340-6868
DOI - 10.1007/s12282-019-01021-x
Subject(s) - medicine , guideline , breast cancer , clinical practice , alternative medicine , family medicine , cancer , medical education , pathology
The Breast Cancer Clinical Practice Guidelines, 2018 edition, written in Japanese and organized by the Japanese Breast Cancer Society, were published in Japanese in May 2018. The process of making these guidelines, as well as the content, was largely changed and compared with previous editions. The concept of these guidelines is to act as a support tool for shared decision making between doctor and patient. The procedure of creating the guidelines referred to Minds Handbook for Clinical Practice Guideline Development 2014. This guideline, written in Japanese, consists of two booklets: (1) the epidemiology and diagnosis booklet covering screening, radiological, and pathological diagnosis and (2) the treatment booklet covering surgical therapy, radiation therapy, and systemic therapy. This review article consists of five parts, including the history of the Breast Cancer Clinical Practice Guidelines, the concept, process, content, and recommendation grade. I believe this brief summary concerning the Breast Cancer Clinical Practice Guidelines 2018 edition in English will be helpful for both Japanese and foreign investigators.